|4Oct 29, 4:56 PM ET

Bernick Brian 4

4 · TherapeuticsMD, Inc. · Filed Oct 29, 2019

Insider Transaction Report

Form 4
Period: 2019-10-25
Transactions
  • Purchase

    Common Stock

    2019-10-25$2.75/sh+36,000$99,00098,000 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    6,557,371
  • Common Stock

    (indirect: See Footnote)
    3,000
Footnotes (3)
  • [F1]Represents a purchase from the underwriters in the issuer's public offering.
  • [F2]The reported securities are owned by BF Investment Enterprises, Ltd. ("BF Investment"). The reporting person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the "GP"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F3]The reported securities are owned by the GP. As disclosed in Footnote 2 above, the reporting person, together with his spouse as tenants by the entirety, holds a 70.6% membership interest in the GP. The reporting person disclaims beneficial ownership of the reported securities held by the GP, except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    bernick-form4_102519.xmlPrimary

    OWNERSHIP DOCUMENT